Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

BSX

BOSTON SCIENTIFIC CORP

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 885725Held by 17 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$20.07B
Net Income FY2025
$2.89B
EPS (Basic, as reported)
$1.96
Net Margin FY2025
14.4%
ROE FY2025
11.9%
Total Equity
$24.23B
Shares Out
1.45B
Business description

BOSTON SCIENTIFIC CORP — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 8,386 → 20,074 +10.2% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue8,3869,0489,82310,7359,91311,88812,68214,24016,74720,074
Cost of revenue(2,424)(2,593)(2,813)(3,116)(3,465)(3,711)(3,956)(4,345)(5,257)(6,221)
Gross profit5,9626,4557,0117,6206,4488,1778,7279,89611,49013,854
Selling, general & administrative(3,099)(3,294)(3,569)(3,941)(3,787)(4,359)(4,520)(5,190)(5,984)(6,887)
Total operating expenses(5,515)(5,170)(5,504)(6,102)(6,528)(6,978)(7,078)(7,553)(8,887)(10,241)
Operating income4471,2851,5061,518(80)1,1991,6492,3432,6033,613
Interest expense(233)(229)(241)(473)(361)(341)(470)(265)(305)(349)
Other income (expense), net(270)(353)(85)(831)1(123)(508)(358)(321)(228)
Pre-tax income1779331,422687(79)1,0761,1411,9852,2823,385
Income tax expense(170)(828)(249)(4,013)(2)(36)(443)(393)(436)(493)
Net income3471041,6714,700(82)1,0416981,5921,8462,892
EPS — basic$0.26$0.08$1.21$3.38($0.08)$0.69$0.45$1.08$1.26$1.96
EPS — diluted$0.25$0.08$1.19$3.33($0.08)$0.69$0.45$1.07$1.25$1.94
Shares outstanding — basic (M)1,3581,3701,3811,3921,4171,4221,4311,4531,4721,480
Shares outstanding — diluted (M)1,3771,3931,4011,4111,4171,4341,4401,4641,4861,495

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.